1. Design, structure-activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin-based sulfamates as steroid sulfatase inhibitors.
- Author
-
Chiu PF, Lin IC, Lu YL, Chang CN, Chan HY, Lin TS, Tsai KC, Hsieh YSY, Chen MJ, Lin MH, and Liang PH
- Subjects
- Pregnancy, Female, Humans, Kinetics, Structure-Activity Relationship, Sulfonic Acids, Coumarins pharmacology, Coumarins therapeutic use, Enzyme Inhibitors pharmacology, Enzyme Inhibitors therapeutic use, Steryl-Sulfatase, Breast Neoplasms drug therapy
- Abstract
Inhibition of steroid sulfatase (STS) decreases estrogen production and thus, suppresses tumor proliferation. Inspired by irosustat, the first STS inhibitor in clinical trials, we explored twenty-one tricyclic and tetra-heterocyclic coumarin-based derivatives. Their STS enzyme kinetic parameters, docking models, and cytotoxicity toward breast cancer and normal cells were evaluated. Tricyclic derivative 9e and tetracyclic derivative 10c were the most promising irreversible inhibitors developed in this study, with K
I of 0.05 and 0.4 nM, and kinact /KI ratios of 28.6 and 19.1 nM-1 min-1 on human placenta STS, respectively., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF